US Stock MarketDetailed Quotes
LPTX Leap Therapeutics
- 3.2500
- +0.1500+4.84%
Trading May 1 15:52 ET
124.36MMarket Cap-816P/E (TTM)
3.2700High3.1200Low106.37KVolume3.1400Open3.1000Pre Close342.07KTurnover0.43%Turnover RatioLossP/E (Static)38.26MShares10.200052wk High2.07P/B80.51MFloat Cap1.235052wk Low--Dividend TTM24.77MShs Float102.5000Historical High--Div YieldTTM4.84%Amplitude1.2350Historical Low3.2150Avg Price1Lot Size
Leap Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 10.79%-43.75M | 20.24%-10.38M | 14.40%-10.49M | 16.92%-10.19M | -10.26%-12.7M | -39.50%-49.04M | -21.44%-13.01M | -51.23%-12.25M | -58.14%-12.26M | -34.13%-11.52M |
| Net income from continuing operations | -49.12%-81.41M | -3.00%-12.47M | 9.26%-13.7M | 21.35%-13.39M | -303.46%-41.86M | -34.52%-54.6M | -12.18%-12.1M | -35.51%-15.09M | -78.71%-17.02M | -13.60%-10.38M |
| Operating gains losses | -97.86%13K | -34.86%-940K | -37.92%501K | -73.40%195K | 209.36%257K | 60.42%608K | -2,148.39%-697K | 210.38%807K | 468.22%733K | -1,219.05%-235K |
| Depreciation and amortization | -6.25%15K | 0.00%4K | 1.49%-199K | 0.00%106K | -3.70%104K | -44.83%16K | -50.00%4K | -2,985.71%-202K | 1,414.29%106K | 1,442.86%108K |
| Other non cash items | 7,417.29%29.99M | 9.28%106K | --306K | --0 | --29.58M | -24.29%399K | -53.59%97K | ---- | ---- | ---- |
| Change In working capital | 485.71%2.51M | 193.74%1.66M | 90.90%1.3M | -38.38%1.64M | 5.81%-2.09M | -164.26%-651K | -68.54%-1.77M | -60.13%681K | 232.50%2.66M | -400.90%-2.22M |
| -Change in receivables | 229.04%1.3M | 102.89%23K | 335.21%1.85M | 50.50%-297K | -631.58%-278K | 12.94%-1.01M | -291.13%-797K | 132.32%426K | -152.10%-600K | -90.00%-38K |
| -Change in prepaid assets | -60.58%164K | 138.24%81K | 232.61%153K | 186.44%169K | -186.28%-239K | 165.10%416K | 106.16%34K | -2.13%46K | 6,000.00%59K | 308.27%277K |
| -Change in payables and accrued expense | -24.66%712K | 240.59%1.72M | -141.94%-624K | -40.47%1.81M | 7.26%-2.2M | -75.77%945K | -25.59%-1.22M | -56.04%1.49M | 176.75%3.05M | -711.89%-2.37M |
| -Change in other current assets | 199.07%748K | -133.76%-53K | 101.86%22K | -78.13%56K | 4,418.75%723K | -226.47%-755K | -73.70%157K | ---1.18M | --256K | --16K |
| -Change in other current liabilities | -3.75%-415K | -10.31%-107K | -10.53%-105K | -0.98%-103K | 5.66%-100K | 1.48%-400K | 45.20%-97K | -206.45%-95K | -198.08%-102K | 64.90%-106K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | 111.88%152K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 10.79%-43.75M | 20.24%-10.38M | 14.40%-10.49M | 16.92%-10.19M | -10.26%-12.7M | -39.50%-49.04M | -21.44%-13.01M | -51.23%-12.25M | -58.14%-12.26M | -34.13%-11.52M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 48.97M | 0 | 0 | -348K | 49.32M | 0 | 0 | 0 | 0 | 0 |
| Net business purchase and sale | --50.36M | --0 | --0 | --0 | --50.36M | --0 | --0 | --0 | --0 | --0 |
| Net other investing changes | ---1.39M | --0 | --0 | ---348K | ---1.05M | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --48.97M | --0 | --0 | ---348K | --49.32M | --0 | --0 | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 85.71%-30K | -1K | 0 | 0 | 86.19%-29K | -100.21%-210K | 0 | 0 | 0 | -1,600.00%-210K |
| Net common stock issuance | ---1K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | ---29K | --0 | --0 | --0 | ---29K | --0 | --0 | --0 | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | -14.13%-210K | --0 | --0 | --0 | ---210K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 85.71%-30K | --0 | ---1K | --0 | 86.19%-29K | -100.21%-210K | --0 | --0 | --0 | -1,600.00%-210K |
| Net cash flow | ||||||||||
| Beginning cash position | -43.00%65.5M | 3.11%80.74M | 0.59%91.42M | -1.15%102.04M | -43.00%65.5M | 120.69%114.92M | -37.24%78.31M | 154.33%90.88M | 137.34%103.22M | 120.69%114.92M |
| Current changes in cash | 110.53%5.19M | 20.24%-10.38M | 14.40%-10.49M | 14.08%-10.53M | 411.97%36.59M | -178.33%-49.25M | -30.65%-13.01M | -113.74%-12.25M | -58.22%-12.26M | -36.80%-11.73M |
| Effect of exchange rate changes | 73.46%-43K | 35.92%280K | 43.17%-183K | -15.38%-90K | -256.25%-50K | -390.91%-162K | 94.34%206K | -161.79%-322K | -766.67%-78K | 557.14%32K |
| End cash Position | 7.85%70.64M | 7.85%70.64M | 3.11%80.74M | 0.59%91.42M | -1.15%102.04M | -43.00%65.5M | -43.00%65.5M | -37.24%78.31M | 154.33%90.88M | 137.34%103.22M |
| Free cash flow | 10.79%-43.75M | 20.24%-10.38M | 14.40%-10.49M | 16.92%-10.19M | -10.26%-12.7M | -39.50%-49.04M | -21.44%-13.01M | -51.23%-12.25M | -58.14%-12.26M | -34.13%-11.52M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg